Neoplasms Metastasis Terminated Phase 4 Trials for Cetuximab (DB00002)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00327093Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver MetastasesTreatment